Press Releases

Advanced Cell Technology To Webcast 2011 Annual Stockholder's Meeting To be Held on Thursday, June 9th

Company to Address Questions from Shareholders Submitted Electronically

MARLBOROUGH, Mass. - June 3, 2011 - Advanced Cell Technology, Inc. ("ACT"; OTC Bulletin Board: ACTC), a leader in the field of regenerative medicine, announced today that it will webcast its Annual Stockholder's Meeting to be held on Thursday, June 9th. The webcast will begin at 9:30 am pacific time, after the Company completes the formal portion of the meeting, where results of proxy voting will be announced. At that time, Gary Rabin, ACT's interim Chairman and CEO, along with other members of the management team, will deliver a Company presentation and address questions from shareholders.

The presentation will be available live and via replay on the home page of ACT's website at: http://www.advancedcell.com.

Investors may submit questions to jyoung@ceocast.com with the subject line "Shareholder Meeting" up until 4 p.m. eastern time on Wednesday, June 8th. The Company will address as many questions as time permits. Investors may also email questions to the same address while the presentation is ongoing, and if time permits, those questions will be addressed as well.

About Advanced Cell Technology, Inc.
Advanced Cell Technology, Inc. is a biotechnology company applying cellular technology in the field of regenerative medicine. For more information, visit http://www.advancedcell.com.

Forward-Looking Statements
Statements in this news release regarding future financial and operating results, future growth in research and development programs, potential applications of our technology, opportunities for the company and any other statements about the future expectations, beliefs, goals, plans, or prospects expressed by management constitute forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Any statements that are not statements of historical fact (including statements containing the words "will," "believes," "plans," "anticipates," "expects," "estimates," and similar expressions) should also be considered to be forward-looking statements. There are a number of important factors that could cause actual results or events to differ materially from those indicated by such forward-looking statements, including: limited operating history, need for future capital, risks inherent in the development and commercialization of potential products, protection of our intellectual property, and economic conditions generally. Additional information on potential factors that could affect our results and other risks and uncertainties are detailed from time to time in the company's periodic reports, including the report on Form 10-K for the year ended December 31, 2010. Forward-looking statements are based on the beliefs, opinions, and expectations of the company's management at the time they are made, and the company does not assume any obligation to update its forward-looking statements if those beliefs, opinions, expectations, or other circumstances should change. Forward-looking statements are based on the beliefs, opinions, and expectations of the company's management at the time they are made, and the company does not assume any obligation to update its forward-looking statements if those beliefs, opinions, expectations, or other circumstances should change. There can be no assurance that the Company's clinical trials will be successful.

Contact:

Investors:
CEOcast, Inc., James Young, 212-732-4300

Press:
ACT Corporate Communications, Bill Douglass, 646-450-3615
or:
Russo Partners, Martina Schwarzkopf, Ph.D., 212-845-4292